Cancer research trials involve patients in medical research. They help us to understand cancer stages, cancer symptoms and develop drugs and treatments that will eventually enable us to cure cancer. We work with volunteers fighting cancer to test new therapy and make that breakthrough.
Learn more about what cancer trials are and what is involved in taking part in one: http://www.cancerresearchuk.org/cancer-help/trials/

Speaking after her TEDxUCD 2016 talk Professor Michaela Higgins said, “We are seeing an exponential increase in cancer cases in the developing world as we improve the control of infant mortality rates and infectious diseases. 70% of all cancer deaths are occurring in Africa, Asia, Central and South America, yet nearly 90% of the $100 billion currently being used to treat cancers is spent in Europe, USA and Japan.”
“As I outlined in my TEDxUCD 2016 talk to reduce this imbalance, and taking into account that most cancers have a lifestyle or environmental cause, we need to stop smoking, eat healthily and vaccinate against common cancer-causing viruses.”
Prior to Professor Higgins current appointment, Michaela was an Assistant Professor of Medicine at Harvard Medical School and a Consultant Physician at Massachusetts General Hospital, Boston.
While in Boston, Michaela was involved with the development of a small oncology service over an 18-month period, at Hôpital Universitaire de Mirebalais in Haiti. This was with support from Partners in Health, a not-for-profit corporation working to bring the benefits of modern medical science to those most in need, in Haiti and around the world.
She is a member of Cancer Research UK’s Clinical Trials Awards and Advisory Committee and the Mater Hospital Lung Cancer Working Group. She serves on the UCD Clinical Research Centre Executive Committee. Michaela is enthusiastic about teaching the next generation of medical doctors, and is particularly interested in global oncology.
Twitter: @ucdmedicine
This talk was given at a TEDx event using the TED conference format but independently organized by a local community. Learn more at http://ted.com/tedx

Dealing with cancer is such a personal journey. One way is not always the best way for someone else. I share my journey as insight for others, but in no way would ever force my decisions or beliefs to anyone. Cancer is a trial for those who have it and for those who help you through it. Every experience is so different and as I have learned inspiring. I hope too that I can inspire those I know and even those I don't know to come to an understanding that life is so much more and it is the way we approach our trials that makes us hopefully stronger and better for it. x

A cottage industry has developed online selling alternative treatments that, unlike the high-street shops, is not bound by the Trade Description or Medicines Act. This has led to a lot of vulnerable people being exposed to some truly insidious products that have the potential to cause a lot of pain and suffering. Perhaps one of the more shocking examples of this is the promotion of a paste called Black Salve (also known as Casema) to people suffering from cancer.
Black Salve is an escharotic substance meaning that when applied directly to the skin, it causes the cells to die – creating a thick black dry clump of necrotic tissue called an “eschar”. This often causes scarring and can potentially cause serious injury and disfigurement. The paste itself is made from a mixture of bloodroot (Sanguinaria canadensis) extract and zinc chloride.
CORRECTION!!! I made a mistake and put a picture of Gail Bumpus and not Ruth Conrad in this video. Sorry about that.
Support Myles through Patreon
http://patreon.com/powerm1985
SCIENCE Kits!
https://mylespower.co.uk/store/
Black Salve
https://mylespower.co.uk/2016/08/23/black-salve/
"Floating Cities" Kevin MacLeod (incompetech.com)
Licensed under Creative Commons: By Attribution 3.0 License
http://creativecommons.org/licenses/by/3.0/
Intro Music by Michael 'Skitch' Schiciano
bio: http://bio.skitchmusic.com
soundcloud: http://www.soundcloud.com/skitchstudio
Subscribe for SCIENCE!
Website: http://www.mylespower.co.uk
Twitter: http://www.twitter.com/#!/powerm1985
Facebook: https://www.facebook.com/powerm1985

Doctors in Sheffield (UK) say patients with multiple sclerosis are showing "remarkable" improvements after receiving a treatment usually used in cancer. They were given bone marrow transplants using their own stem cells to "reset" or "reboot" their faulty immune system. Some patients have been able to walk again after being paralysed. MS affects around 100,000 people in the UK, most of them diagnosed in their 20s and 30s.
Subscribe to BBC News HERE http://bit.ly/1rbfUog
Check out our website: http://www.bbc.com/news
Facebook: http://www.facebook.com/bbcworldnews
Twitter: http://www.twitter.com/bbcworld
Instagram: http://instagram.com/bbcnews

The Irish Cancer Society is investing €7.5 million over the next five years to establish the first ever Collaborative Cancer Research Centres, bringing together the leading clinical researchers, lab researchers and population researchers in Ireland.
The first Collaborative Cancer Research Centre, BREAST-PREDICT, is launched in August 2013.
Find out more about Collaborative Cancer Research Centres at www.cancer.ie/CollaborativeCancerResearchCentres.

Martin J. Murphy, DMedSc, PhD and Bruce Chabner, PhD
Overview of the three major themes of STO's meeting: new targeted agents, strategies for profiling and selection of patients for targeted drug trials, and biomarkers and animal models to guide clinical development.

Prof Patrick Johnston, Centre for Cancer Research & Cell Biology, Queen's University Belfast, discusses his work targeting the BCL2 protein family and other inhibitors of cell apoptosis in order to prevent cancer cells resisting chemotherapy. Agents such as Obatoclax, ABT243 and proteins such as c-FLIP. For cancers such as lung, prostate, breast and ovarian.

After a CT scan revealed a 5 cm mass on his lung, lung cancer patient Tom Barber underwent a video-assisted thoracotomy at The University of Texas MD Anderson Cancer Center in August 2009. He subsequently considered chemotherapy and a clinical trial for follow-up lung cancer treatment.
Ultimately, Barber chose to participate in a clinical trial. Although he experienced many side effects as a result of the clinical trial, he encourages other cancer patients to participate in a clinical trial, if there's one that's appropriate for their particular cancer diagnosis. Today, Barber is lung cancer-free.
Read Barber's story: http://www.cancermoonshots.org/stories-hope/tom-barber
Learn about MD Anderson's Lung Cancer Moon Shot: http://www.cancermoonshots.org/moon-shots/lung

The number of cancer cases is expected to continue to rise. But at The University of Texas MD Anderson Cancer Center, we're focused on eliminating cancer through innovative cancer treatment options, clinical trials and cancer research. We understand that cancer represents more than 100 different diseases, that different types of cancer behave differently and need to be treated differently, and that each patient's cancer requires personalized cancer treatment.
We treat more cancers a day than many doctors see in their entire careers. But we don't just treat cancer. Our cancer researchers also are pioneering new cancer therapies, such as immunotherapy, and are identifying new ways to prevent cancer and to find cancer at its earliest stages, when it's easiest to treat.
Our employees never forget our focus -- our patients -- and we strive to make sure they receive the compassionate care they deserve each day. This shows in our consistently high patient satisfaction scores.
It's not just our doctors, employees, graduate students and trainees who have helped make MD Anderson a global leader in cancer care, cancer research and cancer education. Our cancer patients, cancer survivors, volunteers and donors also play an essential role in our efforts to end cancer. #endcancer
Learn more about MD Anderson: http://www.mdanderson.org/about-us/index.html
Request an appointment at MD Anderson: https://www4.mdanderson.org/contact/selfreferral/index.cfm

With exciting data for immuno-oncology in lung cancer, there is much anticipation for what 2018 holds. In this interview, Solange Peters, MD, PhD, of Lausanne University Hospital, Lausanne, France, updates us on the immunotherapy trial data to look out for in 2018. Prof. Peters also discusses what she hopes the European Society of Medical Oncology (ESMO) 2018 Congress later in the year will have on the agenda in this field. This video was recorded at the British Thoracic Oncology Group (BTOG) Annual Conference 2018, held in Dublin, Ireland.

We call dogs man's best friend, and now the four-legged animals are helping doctors create a new way to fight cancer in humans that could eliminate the need for surgery or chemotherapy. It's being researched at the KU Cancer Center.

Sar is a 63-year-old lady diagnosed with Stage 3 Colon Cancer in 2008. Her daughters decided to bring their mom to Singapore to get the best possible treatment. She had surgery followed by radiotherapy, but no chemotherapy. In June 2009, her cancer had spread to her lungs. She went for chemotherapy, but in less than a year, her cancer progressed further. She had more chemotherapy and her cancer continued to progress. It was meaningless.

Diagnosed with non-small cell lung cancer at age 76, Jackie Raser underwent more than a year of intense chemotherapy at a nearby hospital only to be told that the tumor's growth couldn't be stopped and she had just months to live. When she turned to UC Irvine Health, Raser says, Dr. Ignatius Ou "gave me a second chance."
After enrolling in a clinical trial for the drug crizotinib led by oncologist Dr. Ignatius Ou at UC Irvine Health Chao Family Comprehensive Cancer Center, the now 83-year-old Raser is living a full, active life.
Ou̕'s care of Raser is changing the way lung cancer is treated nationwide. More than two dozen lung cancer trials are underway at UC Irvine Health. If you're interested in learning more, call 714-456-8000 or visit http://www.ucirvinehealth.org/lungcancer.
#TheAntiCancer | http://www.anti-cancer.com
Read more about Jackie's story: http://www.ucirvinehealth.org/meetjackie
Get patient stories, wellness tips, health care news and more on our Live Well blog:
http://www.ucirvinehealth.org/blog
UC Irvine Health | http://www.ucirvinehealth.org

Subscribe to BBC News www.youtube.com/bbcnews
The BBC's Alastair Leithead reports on how evidence is growing that cannabis could cure diseases like cancer. The medical value of cannabis has been hotly debated for years. Its use as a relaxant or a pain reliever is widely accepted now.
Subscribe to BBC News HERE http://bit.ly/1rbfUog
Check out our website: http://www.bbc.com/news
Facebook: http://www.facebook.com/bbcworldnews
Twitter: http://www.twitter.com/bbcworld
Instagram: http://instagram.com/bbcnews

This disturbing film tells the inside story of a mother, Terri Milbrandt, who pretended her daughter had cancer and appealed to her close- knit community for help to pay the medical bills. Seven-year-old Hannah had her head shaved and was given sleeping pills by her mother. It seems that when she awoke she was told she had had chemotherapy. Her teachers arranged counselling for Hannah to prepare her for her death and when she visited Santa she asked to be spared. But there was no cancer and there were no medical bills. Now that close-knit community wants justice and a jury must decide whether they were the victims of a sadistic fraud.
This film talks exclusively to Bob Milbrandt, Hannah's father, who is standing trial for conspiracy to the crimes of theft, child endangerment and felonious assault, and to Hannah's grandmother who is also standing trial for theft. Friends, fundraisers and police investigators reveal how it took nine months to discover the story was false.
Want to watch more full-length Documentaries?
Click here: http://bit.ly/1GOzpIu
Follow us on Twitter for more - https://twitter.com/realstoriesdocs
Facebook - https://www.facebook.com/RealStoriesChannel
Instagram - @realstoriesdocs
Content licensed from Digital Rights Group (DRG). Any queries, please contact us at: realstories@littledotstudios.com
Produced by Mentorn Films

It's been whirlwind since finding out that I had Stage 2 Malignant Melanoma yesterday and today we are heading in to get it removed along with a margin of skin around it. We're grateful that it wasn't worse but also a little nervous about the procedure.
Don't forget to visit us here:
***http://www.knorppandsouth.com/
***http://www.instagram.com/knorpp_and_south
***https://www.facebook.com/knorppandsouth/
Interested in learning about essential oils? Come join our facebook group to learn all about how we use them and how you can get some!
https://www.facebook.com/groups/394188214360308/?fref=nf
Want to know what we do for a living and how you can do it too? Come hang out in this facebook group and learn all about it!
https://www.facebook.com/groups/2031230140471379/
Want to listen to the music in this vlog?
Visit Epidemic Sound and get a free trial!
https://goo.gl/DAQ311

Matthew Hatton, MSc, MBChB, MRCP, FRCP, FRCR, Weston Park Hospital, Sheffield, UK, is the chair of the NCRI Lung Clinical Studies Group. The group’s remit is to develop the trial portfolio for lung cancer in order to cover areas that are not particularly well covered by the pharmaceutical industry. Such areas include screening, early diagnosis, radiotherapy, surgery, supportive care, and palliative care. The goal is that, ultimately, clinical trials become an option for all lung cancer patients as part of their disease management and treatment.
Recorded at the 2017 meeting of the British Thoracic Oncology Group (BTOG) in Dublin, Ireland.

Since 1996 Prof Patrick Johnston, Queens University Belfast, UK has led the development of the Belfast City Hospital Cancer Centre and has built up this centre to the point where it now carries out a substantial number of clinical trials, takes part in international research and in 2006 opened the centre for cancer research and cell biology. The centre offers the latest imaging and treatment technologies and was recognised as one of first CRUK centres in 2008.
Prof Johnston speaks about the key areas of his research these including the relationship between DNA damage and death signalling, work identifying factors that determine whether an EGFR inhibitor is likely to be synergistic with chemotherapeutic agents, and the targeting of ADAM-17 (an enzyme associated with chemotherapy resistance).

Around 30 patients suffering from advanced melanoma cancer are being enrolled in a clinical trial in Cork, with early results indicating improved survival rates. Copyright: RTE News
The trial involves a combination of two existing treatments.
Doctors are being encouraged to refer suitable patients for inclusion in the clinical trial, which is being offered by Cork Cancer Research Centre at Cork University Hospital.
Scientists believe that delivering an electrical pulse or shock directly to the tumour, along with an immunotherapy drug called IPI and low-dose chemotherapy will improve survival rates for advanced melanoma cancer patients.
Doctors involved in the clinical trial believe the new treatment will be widely adopted and have described it as one of the first of its kind in the world.
http://www.ccrc.ie http://www.breakthroughcancerresearch.ie

(from wikipedia - Living Proof)
Living Proof is a 2008 Lifetime Television movie, directed by Dan Ireland, starring Harry Connick, Jr.
The film is based on the true life story of Dr. Dennis Slamon and the book "HER-2: The Making of Herceptin, a Revolutionary Treatment for Breast Cancer" by Robert Bazell. Renée Zellweger is on of the executive producers, together with Neil Meron and Craig Zadan.
The film follows the true story of Dr. Dennis Slamon (played by Harry Connick, Jr.), who helped develop the breast cancer drug Herceptin, over the course of 8 years from 1988 to 1996. Dr. Slamon is a research doctor at UCLA Medical Center (Los Angeles), where he has developed the experimental drug Herceptin, which he believes will become a treatment for breast cancer.
Prior to the trials, the drug has a "mouse trial", with Nicole (Tammy Blanchard), a young mother with stage 4 cancer, receiving the drug first. Although her mother Elizabeth (Swoosie Kurtz) pleads with Dr. Slamon, Nicole is not included in the subsequent trials as she does not meet the protocols. The women in the trials, particularly the first trial, band together. They handle their disease and drug trial, with humor—Tish (Jennifer Coolidge), or with alternative therapy—Tina (Trudie Styler). The stories of Barbara (Bernadette Peters) and Ellie (Regina King) are followed throughout, as they go through the trials and eventual recovery. Some patients involved in the tests die, but ultimately Slamon's work with the drug changes the course of breast cancer treatment.
Tammy Blanchard, Amanda Bynes, Jennifer Coolidge, Angie Harmon, John Benjamin Hickey, Regina King, Swoosie Kurtz, Paula Cale Lisbe, Amy Madigan, Bernadette Peters, and Trudie Styler are featured in the supporting cast.
Association website: http://www.efp-online.fr
Online education: http://www.invivoveritas.fr

Jeff was diagnosed with advanced lung cancer that had spread to his brain. His tumor tested positive for the ALK gene translocation so his treatment changed from chemotherapy to a targeted therapy that was more effective and had fewer side effects. Four years later, Jeff is still doing well. Learn how Dana-Farber/Brigham and Women's Cancer Center is delivering on the promise of cancer precision medicine.
Transcription:
Jeff: My name is Jeff. I’ve lived in the greater Boston area my whole life. I’m married, and I have two children. My wife is Tina, my daughter is Sophie, and my son is Noah. For a week or so, a couple people who I had spent a lot of time with noticed that I wasn’t acting quite normally, my wife didn’t think I was acting normally, and my boss didn’t think I was acting normally. I was tired a lot, and in the morning when I would get ready for work—right before I left the house—I’d sit down on a chair or something like that and then—poof!—all of a sudden, it was three hours later, like I would just sleep there and not know it and then frantically show up for work late for a couple days.
One Saturday, my wife and I went to a food and wine festival where they give you little cups of wine and some snacks to eat, and it turns out I passed out after two of those little cups of wine.
Text: Jeff’s doctor ordered an MRI of his head.
Jeff: He showed me the MRI, and I had a big tumor in the top of my head about the size of a lemon, and he told that I needed to go right to the hospital, and it needed to be removed. They did lots of tests and scans to try to figure out exactly what it was and how best to deal with it. They discovered there was actually lung cancer that had spread to my brain. They also found a very small lung tumor, and they had found additional smaller brain tumors.
Text: Jeff had surgery to remove the tumor, followed by whole brain radiation. Then he had chemotherapy.
Jeff: The following chemo sessions got pretty bad. After the second one, I had to basically lay in bed and sleep for three days, and then after the third one, I slept for five days. It got progressively worse. So, I actually started to get worried about how long I could actually stand chemotherapy, but it was working, so whatever works, I was going to keep doing. My lung tumor was not growing at that point.
Then after five chemotherapy sessions, my tumor did start to grow a little bit. My tumor was sent out for genetic testing to see if I had markers or mutations, and it turns out that my tumor does have an ALK translocation. There was a clinical drug that targeted that. It worked wonderfully. I had very few side effects, and I’ve been scanned repeatedly, and everything looks great.
Text: Jeff meets monthly with his clinicians at Dana-Farber/Brigham and Women’s Cancer Center.
Jeff: The care you receive here has really been excellent. Everybody that I’ve met really seems to me like they're on top of their game. Dr. Jackman was always one step ahead of me, so when he told me he was putting me on chemotherapy to start, he was thinking about what other better things he could move me on. It’s really reassuring knowing that he’s a step ahead of me the whole time. He took a lot of the worry out for me when I figured this out, that he knows where I’m going. He’s got a path for me—I don’t need to worry about it.
Text: After 4 years, Jeff continues doing well on his targeted therapies.
Jeff: There are two things that I’ve realized coming here. One is that there’s tremendous patient care all the time. But the other is there’s tremendous research going on here. When I think about the targeted therapies, they didn’t change my life—they gave me back my old life, which has really been awesome. I wake up in the morning like a normal person. I get myself ready for work. I feed my kids. I do everything regular people do. I’m a little bit different, but not too different.

Queen’s University, in partnership with the Belfast Trust, is leading the world’s first ever trial of a new combination of cancer therapies for patients with advanced prostate cancer, with the hope of prolonging their lives.
Subscribe NOW to Queen’s University Belfast: http://bit.ly/1Y24vux
MORE from Queen’s University Belfast:
Like Queen’s University Belfast: https://www.facebook.com/QueensUniver...
Follow Queen’s University Belfast on Twitter: https://twitter.com/QueensUBelfast
Follow Queen’s University Belfast on Instagram: https://www.instagram.com/queensubelf...
To find out about our courses: http://www.qub.ac.uk/home/StudyatQuee...
To find out about our research: http://www.qub.ac.uk/home/Researchand...
Queen’s University Belfast is a UK Russell Group university based in Belfast, Northern Ireland and here you will find out what Queen’s University Belfast can do for you, whether you want to know about one of hundreds of courses, what our students think about living and studying at Queen’s and in Belfast, and how our researchers are creating impact around the world.
http://qub.ac.uk/

Before Tom Barber received his lung cancer diagnosis, he had a recurring cough that doctors repeatedly treated with antibiotics. A CT scan later revealed a 4-6 cm tumor in the upper lobe of his lung. For his lung cancer treatment, he underwent a video-assisted thoracotomy (also known as a lobectomy) at The University of Texas MD Anderson Cancer Center in August 2009.
Within three weeks, Barber -- now a 4-year lung cancer survivor -- was back at the gym lifting weights. He has subsequently completed 5K and 10K runs, a half-marathon and two triathlons. Barber says his quality of life after lung cancer treatment is even better than it was before lung cancer.
Read Barber's story: http://www.cancermoonshots.org/stories-hope/tom-barber
Learn about MD Anderson's Lung Cancer Moon Shot: http://www.cancermoonshots.org/moon-shots/lung/

Exciting clinical trial updates were presented at the British Thoracic Oncology Group (BTOG) Annual Conference 2018, held in Dublin, Ireland. Speaking from the meeting, Robert Rintoul, PhD, FRCP, of the Cancer Research UK Cambridge Institute, Cambridge, UK, discusses the updates that he presented on the MARS2 (NCT02040272) and MesoTRAP (NCT03412357) studies for mesothelioma. MARS2 is investigating whether pleurectomy/decortication confers a survival advantage, whereas MesoTRAP is a feasibility study comparing pleurectomy/decortication vs. indwelling pleural catheter treatment for trapped lung. Dr Rintoul gives an overview of the progress of the trials thus far, as well as the additional measurements being incorporated, including health economics and QuinteT recruitment intervention.

New era in the war on cancer: Revolutionary treatment that will save thousands hailed as 'biggest breakthrough since chemotherapy'
Immunotherapy teaches body to attack cancer cells and destroy tumours
The treatment will replace chemotherapy within five years, say researchers
It is particularly effective against skin and lung cancer, experts believe
Trial patients expected to only survive months went on to live normal lives
New,era,war,cancer,Revolutionary,treatment,save,thousands,hailed,biggest,breakthrough,chemotherapy

Thousands could be spared chemotherapy after landmark breast cancer study
Hundreds of Irish women, with early stage breast cancer, could avoid the need for chemotherapy as a result of the findings of a major study. More than 10,000 women worldwide, including 690 from Ireland, took part in a major trial that analyses the danger of a tumour. Cancer Trials Ireland led the Irish arm of the study, which found 70% of patients may be able to avoid chemotherapy after surgery. The findings will lead to a “fundamental change” in the way the disease is treated, a leading oncolog...

As part of the Irish Cancer Society's premiere public cancer research talk, Dr Christopher Sweeney of the Dana Farber Institute presents an update on the progress in clinical trials in treating prostate cancer.

Here, Kellie Dean talks about the financial cost and practical impact of a cancer diagnosis.
Over the last five years, the number of cancer patients going through treatment who have asked The Irish Cancer Society for cash support to pay for necessities like heat and travel expenses, has increased by 82%.
Share your story and take part in our nationwide survey of the real cost of cancer on our website: www.cancer.ie/realcost . #RealCostofCancer

Lung cancer is the fourth most common cancer in Ireland, with about 2300 people diagnosed in Ireland every year.
Joe, a lung cancer survivor talks about his diagnosis and treatment for lung cancer.
If you are concerned about lung cancer, call our Cancer Nurseline on 1800 200 700 or talk to others on our online community www.cancer.ie/community.
To find out more information about the signs and symptoms of lung cancer see www.cancer.ie/lung.

When standard therapy failed to stop the advance of Adrienne Skinner’s metastatic ampullary cancer, she turned to a clinical trial of an immunotherapeutic that targeted the genetics of her disease. Adrienne’s story and those of others highlighted in the AACR Cancer Progress Report 2017, show how decades of investment in cancer research are leading to new discoveries that are saving lives today. Read the full report at CancerProgressReport.org.

http://www.dailyrx.com/
A new study found evidence that immunotherapy, which uses the body's own immune system to fight a disease, helped patients with lung cancer live longer than patients treated with chemotherapy.
"In the 20 years that I’ve been in practice, I consider this a major milestone,” said lead study author Julie Brahmer, MD, of Johns Hopkins Medicine's Sidney Kimmel Comprehensive Cancer Center in Baltimore, in a news release.
Dr. Brahmer and team compared traditional chemotherapy treatment to treatment with an immunotherapy medication, nivolumab (sold under the brand name Opdivo).
The study involved 272 patients with squamous-cell non-small-cell lung cancer, a common form of lung cancer where cancer cells form in the tissue lining the lungs. These patients had all received initial chemotherapy, but their cancer was still progressing. In chemotherapy, doctors give patients powerful drugs that attack cancer cells.
The study patients were split into two groups. In the first group, 135 patients received the immunotherapy drug nivolumab. The second group of 137 patients received docetaxel (sold under the brand name Taxotere), a chemotherapy drug.
Overall, Dr. Brahmer and team found better results among the nivolumab group — who had a 41 percent lower relative risk of dying from lung cancer than the chemotherapy group.
The immunotherapy patients had a median overall survival of 9.2 months, compared to six months in the chemotherapy group. The immunotherapy patients also had a median of 3.5 months with out any disease progression, compared to 2.8 months in the chemo group.
And after one year, 42 percent of the patients taking nivolumab were still alive, compared to only 24 percent of the chemotherapy group — nearly a doubled survival rate among the immunotherapy patients.
The patients taking nivolumab also reported fewer and less severe side effects. Only 7 percent of this group reported severe side effects, compared to 55 percent of the chemo patients.

Lung cancer treatment is a complex landscape, with many treatments now available. Head to head clinical trials are needed in order to compare treatments on the same patient populations during the same time frame, and get clearer answers which can help in making the best treatment decisions for patients.

Bill shares his experience receiving care for advanced stage lung cancer at Cleveland Clinic.. He is beating the odds with the help of his incredible multidisciplinary team. Whether it’s surgery, chemotherapy, radiation, immunotherapy or clinical trials – world class care is available to you. To learn more visit clevelandclinic.org/canceranswers.

This lecture, called ‘Breast Cancer - What Do We Know Now?' was delivered by the Head of the School of Medicine and Professor of Surgery at RCSI Professor Arnold Hill and was recorded in the O'Flanagan Lecture Theatre, RCSI on 26th November 2014.
In this talk, Prof Hill will speak about how new breast cancer therapies, and how moving to a more personalised patient approach to managing breast cancer, has changed it from a disease that kills, to one where patients have learned to live and manage it as a chronic illness.
The various options to treating and managing the condition will be discussed and Prof Hill will also detail the future challenges in the battle against breast cancer. He will detail the innovations in surgical techniques which are less invasive and have led to vast improvements in breast reconstruction procedures.

Visit our website: http://www.thetruthaboutcancer.com/
Join TTAC's 500K+ FB fans: https://www.facebook.com/thetruthaboutcancer
Support our mission by commenting and sharing with your friends and family below.
----------------
Summary
----------------
In this video, cancer researcher Ty Bollinger speaks with Dr. Linda Isaacs about why doctors don't prescribe natural treatments for patients. The full interview with Dr. Isaacs is part of "The Quest For The Cures Continues" docu-series.
--------------------------------------------------
About The Truth About Cancer
--------------------------------------------------
The Truth About Cancer’s mission is to inform, educate, and eradicate the pandemic of cancer in our modern world. Every single day, tens of thousands of people just like you are curing cancer (and/or preventing it) from destroying their bodies.
It’s time to take matters into your own hands and educate yourself on real cancer prevention and treatments. It could save your life or the life of someone you love.
----------------------------------------------------------------------
Inside The Truth About Cancer Docu-Series
---------------------------------------------------------------------
Doctors, researchers, experts, and survivors show you exactly how to prevent and treat cancer in our 3 original docu-series: "The Quest For The Cures”, “The Quest For The Cures Continues”, “The Truth About Cancer: A Global Quest”, and on our website: http://www.thetruthaboutcancer.com
In our docu-series you’ll travel with Ty Bollinger who lost both his mother and father to cancer (as well as 5 other family members). Ty travels the country and the globe and sits down with the foremost doctors, researchers, experts, and cancer conquerers to find out their proven methods for preventing and treating cancer.
Please join our email list to be notified of all upcoming events (including free airings of our docu-series): http://thetruthaboutcancer.com
Learn more about our latest docu-series “The Truth About Cancer: A Global Quest” here: https://go2.thetruthaboutcancer.com/g...
-------------
About Ty
-------------
Ty Bollinger is a devoted husband, father, a best-selling author, and a Christian. He is also a licensed CPA, health freedom advocate, cancer researcher, former competitive bodybuilder, and author of the best-selling book "Cancer - Step Outside the Box," which has sold over 100,000 copies worldwide.
After losing his mother and father and several family members to cancer, Ty’s heartbreak and grief coupled with his firm belief that chemotherapy, radiation, and surgery were the NOT the most effective treatments available for cancer patients led him on a path of discovery.
He began a quest to learn everything he possibly could about alternative cancer treatments and the medical industry. What he uncovered was shocking. On his journey, he’s interviewed cutting-edge scientists, leading alternative doctors, and groundbreaking researchers to learn about hidden alternative cancer treatments. What he uncovered help to create The Truth About Cancer and its 3 awe-inspiring docu-series’:”The Quest for The Cures”, “The Quest For The Cures Continues”, and “The Truth About Cancer: A Global Quest.”
Ty has touched the hearts and changed the lives of thousands of people around the world. Ty speaks frequently at conferences, local health group meetings, churches, and is a regular guest on multiple radio and TV shows and writes for numerous magazines and websites.
-----------------------------------
Dr. Linda Isaacs, The Quest For The Cures, Ty Bollinger, The Truth About Cancer, A Global Quest, cancer (disease or medical condition), how to prevent cancer, alternative cancer treatments, natural cancer cures, cancer prevention, cure for cancer, cancer treatment, cancer cure, anti cancer diet, anti-cancer diet, foods that fight cancer, cancer remission, cancer treatments, cancer fighting foods, cancer nutrition and healing, cancer nutrition, cancer and nutrition, cancer and sugar, beating cancer with nutrition, is there a cure for cancer, cancer diet, causes of cancer, nutrition, effect of nutrition on health, nutrition and health, preventative healthcare, holistic medicine, signs of cancer, what is cancer, homeopathic remedies, symptoms of cancer, stages of cancer, alternative medicine, chemo, chemotherapy, radiation, surgery, integrative medicine, cancer research, holistic health, cancer stages, cancer cells, cancer treatment, cancer doctor, cancer statistics, cancers, causes of cancer, childhood cancer, cancer awareness, cancer diet, cancer facts, cancer signs, cancer pain, cancer care, cancer center, how do you get cancer, cancer therapy, cancer survival rates, kill cancer, you are what you eat, junk food, toxins, processed food, GMOs, genetically modified foods

Ashley, 35, was diagnosed with testicular cancer in 2004 when he was 28. Following surgery, Ashley was invited to take part in a clinical trial that Cancer Research UK helped to fund to look at ways to reduce the side effects of one particular chemotherapy drug. During his treatment Ashley was given cisplatin.

The class of drugs that Levitra, Viagra, Stendra, and Cialis belong to are called PDE5 inhibitors. They work by relaxing tight blood vessels, allowing more blood to surge into the penis and cause an erection, says Gregory Bales, M.D., an associate professor of urology at the University of Chicago.
The little pills do the trick for more than two-thirds of men with Viagra protects the heart (ED). They also work for guys who simply need them for a short time to get their “confidence back,” says Michael Eisenberg, M.D., director of male reproductive medicine and surgery at Stanford University.